Ciliary body melanoma: A special challenge

Canadian Journal of Ophthalmology

Volumn 39, Issue 4, 2004, Pages 365-371

  Simpson, E Rand ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Ciliary body melanoma; Metastasis; Ultrasound biomicroscopy

Indexed keywords

BIOMICROSCOPY; CANCER SIZE; CILIARY BODY MELANOMA; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; EARLY DIAGNOSIS; EYE BIOPSY; HUMAN; MELANOMA; METASTASIS; REVIEW;

EID: 3042731737     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(04)80007-3     Document Type: Article

References (26)

1. Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization [abstract]. Cancer Genet Cytogenet 2000;122:13-7.
2. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 1998;83:354-9.
3. Parrella P, Caballero OL, Sidransky D, Merbs SL. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest Ophthalmol Vis Sci 2001;42:1679-84.
4. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumour angiogenesis. Am J Pathol 2000; 156:361-81.
5. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, et al. The prognostic value of tumour blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100:1389-98.
6. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology 1995;102(5):844-51.
7. Foss AJ, Alexander RA, Hungerford JL, Harris AL, Cree IA, Lightman S. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol 1997;81:240-6; discussion 247-8.
8. Mehaffey MG, Gardner LM, Folberg R. Distribution of prognostically important vascular patterns across multiple levels in ciliary body and choroidal melanomas. Am J Ophthalmol 1998;126(3):373-8.
9. Seftor REB, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001;61:6322-7.
10. Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-66.
11. Maberley DAL, Pavlin CJ, McGowan HD, Foster FS, Simpson ER. Ultrasound biomicroscopic imaging of the anterior aspect of peripheral choroidal melanomas. Am J Ophthalmol 1997;123(4):506-14.
12. Pavlin CJ, McWhae JA, McGowan HD, Foster FS. Ultrasound biomicroscopy of anterior segment tumors. Ophthalmology 1992;99:1220-8.
13. Demirci H, Shields CL, Shields JA, Honavar SG, Eagle RC Jr. Ring melanoma of the ciliary body: report on twenty-three patients. Retina 2002;22(6):698-706.
14. Pavlin CJ, Foster FS. Ultrasound biomicroscopy of the eye. New York: Springer-Verlag; 1995. p. 119-22.
15. Shields JA, Shields CL, Ehya H, Eagle RC Jr, De Potter P. Fine-needle aspiration biopsy of suspected intraocular tumours. The 1992 Urwick Lecture. Ophthalmology 1993;100:1677-84.
16. Ballin R, Lommatzsch PK, Drost H, Ratajek B. [A beta ray applicator (106 Ru/106Rh) in the treatment of ciliary body melanomas.] Klin Monatsbl Augenheilkd 1985; 187:144-6.
17. Finger PT. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol 2001;132:328-35.
18. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-32.
19. Gragoudas ES, Seddon JM, Egan KM, Polivogianis L, Hsieh CC, Goitein M, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology 1986;93:675-80.
20. Collaborative Ocular Melanoma Study Group. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS Report No. 6. Am J Ophthalmol 1998;125: 745-66.
21. Gündüz K, Shields CL, Shields JA, Cater J, Brady L. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol 2000;130(1):97-102.
22. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 2001;119:670-6.
23. 60Co episcleral plaque therapy. Ophthalmology 1989;96:382-8.
24. Gambrelle J, Kodjikian L, Rouberol F, Donate D, Duquesne N, Jean-Louis B, et al. [Ciliary body melanomas. Survival and prognostic aspect after brachytherapy or proton therapy.] J Fr Ophtalmol 2004; 27(1):40-7.
25. Figueiredo A, Caissie AL, Callejo SA, McLean IW, Gold P, Burnier MN Jr. Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours. Can J Ophthalmol 2003;38(5):352-6.
26. Augustin HG, Breier G. Angiogenesis: molecular mechanisms and functional interactions - 2nd Kloster Seeon Meeting of the German Priority Research Grant "Angiogenesis." Thromb Haemost 2003;89:190-7.